| Literature DB >> 12435270 |
Yoshiyuki Mizushina1, Xianai Xu, Hitomi Asahara, Ryo Takeuchi, Masahiko Oshige, Noriko Shimazaki, Masaharu Takemura, Toyofumi Yamaguchi, Kazufumi Kuroda, Stuart Linn, Hiromi Yoshida, Osamu Koiwai, Mineo Saneyoshi, Fumio Sugawara, Kengo Sakaguchi.
Abstract
Sulphoquinovosyl diacylglycerol (SQDG) was reported as a selective inhibitor of eukaryotic DNA polymerases alpha and beta [Hanashima, Mizushina, Ohta, Yamazaki, Sugawara and Sakaguchi (2000) Jpn. J. Cancer Res. 91, 1073-1083] and an immunosuppressive agent [Matsumoto, Sahara, Fujita, Shimozawa, Takenouchi, Torigoe, Hanashima, Yamazaki, Takahashi, Sugawara et al. (2002) Transplantation 74, 261-267]. The purpose of this paper is to elucidate the biochemical properties of the inhibition more precisely. As expected, SQDG could inhibit the activities of mammalian DNA polymerases such as alpha, delta, eta and kappa in vitro in the range of 2-5 micro M, and beta and lambda in vitro in the range of 20-45 micro M. However, SQDG could inhibit only mammalian DNA polymerases epsilon (pol epsilon) activity at less than 0.04 micro M. SQDG bound more tightly to mammalian pol epsilon than the other mammalian polymerases tested. Moreover, SQDG could inhibit the activities of all the polymerases from animals such as fish and insect, but not of the polymerases from plant and prokaryotes. SQDG should, therefore, be called a mammalian pol epsilon-specific inhibitor or animal polymerase-specific inhibitor. To our knowledge, this represents the first report about an inhibitor specific to mammalian pol epsilon.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12435270 PMCID: PMC1223160 DOI: 10.1042/BJ20021737
Source DB: PubMed Journal: Biochem J ISSN: 0264-6021 Impact factor: 3.857